|
|
||||||||
ORIGINAL ARTICLE |
1 Clinical Research Group "Chronic Airway Diseases", Medical Faculty, Philipps-University Marburg, Germany
2 Dept of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine and Center for Health and the Environment, University of California, Davis, California, 95615, USA
* To whom correspondence should be addressed. E-mail: ayildiri{at}med.uni-marburg.de.
| Abstract |
|---|
Airway epithelial cells are exposed to environmental toxicants that result in airway injury. Naphthalene (NA) causes site selective damage to Clara cells in mouse distal airways.
N23-KGF protects against acute lung injury. This study investigated whether
N23-KGF protects against NA-induced acute Clara cell damage by measuring airway responses specifically and to identify underlying molecular mechanisms.
Mice were treated with
N23-KGF or PBS 33h prior to injection of 200 mg·kg-1 NA. Lung function was analysed by head-out body plethysmography. Distal airways isolated by microdissection were assessed by ethidium homodimer-1 for cell permeability. Immunohistochemistry for Clara cell specific protein in conjunction with a physical disector was used to quantify Clara cell numbers. RNA was isolated from frozen airways to analyse gene expression by quantitative RT-PCR.
N23-KGF prevented NA-induced airflow limitation and Clara cell permeabilty, and resulted in twice as many Clara cells compared to PBS pre-treatment.
N23-KGF pre-treated mice exhibited increased mRNA expression for proliferating cell nuclear antigen. Cytochrome P450 isoform 2F2 (CYP2F2), which converts NA into its toxic metabolite, was reduced by about 50%.
Our results demonstrate that pre-treatment with
N23-KGF protects against NA-induced injury. We suggest that
N23-KGF exerts its beneficial effect through a decrease in the expression of CYP2F2.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |